Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Optimizing Clinical Care Delivery for Patients with Multiple Myeloma Receiving Bispecific AntibodiesRelease Date:Quality Improvement Oncology All Enhancing HCP Education in Maternal VaccinationRelease Date:Education Vaccines Saudi Arabia Diagnosis and Treatment of Cancer CachexiaRelease Date:Education Oncology All Evidence-Based Education on the Potential Impact of a Generic JAK Inhibitor on the Management of Rheumatologic DiseasesRelease Date:Education Inflammation & Immunology USA B-cell Maturation Antigen (BCMA) Bi-Specific Antibodies (BsAbs) in Relapsed/Refractory Multiple Myeloma (RRMM)Release Date:Education Oncology USA Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia AreataRelease Date:Education Inflammation & Immunology USA 2026 Hemophilia Fellowship – United StatesRelease Date:Fellowship Rare Disease All Pediatric Pneumococcal Disease and Serotype Distribution: Surveillance Studies in Saudi ArabiaRelease Date:Research Vaccines Saudi Arabia Optimising Ulcerative Colitis Care: Bridging Knowledge Gaps, Integrating Biomarker-Based Strategies, and Advancing EquityRelease Date:Education Inflammation & Immunology Australia Surveillance of Pneumococcal Disease Serotype Distribution in Pediatric and Adult Pneumococcal Disease in TürkiyeRelease Date:Research Vaccines Turkey Surveillance of Pneumococcal Disease Serotype Distribution in Pediatric and Adult Pneumococcal Disease in TürkiyeRelease Date:Research Vaccines Turkey Title Grant Type Focus Area Country Application Due Date Improving the Care of Persons Living with Metastatic Breast CancerRelease Date:Partner: Rethink Breast CancerQuality Improvement Oncology Canada Addressing knowledge and practice gaps in changing paradigms of dermatological inflammatory conditionsRelease Date:Education Inflammation & Immunology Canada Improving Advanced Prostate Cancer Management in Latin AmericaEducation Oncology Argentina, Brazil, Chile, Colombia, Mexico Investigating the Value of Using Patient-Reported Outcomes in Oncology Patient CareResearch Oncology USA Addressing Knowledge Gaps in Ulcerative Colitis (UC) CareRelease Date:Education Inflammation & Immunology USA 2024 Inflammatory Bowel Disease (IBD) Fellowship – United StatesRelease Date:Fellowship Inflammation & Immunology USA Closing the HRRm Testing Gap in Prostate Cancer PatientsRelease Date:Quality Improvement Oncology Canada Improving the care and outcomes of residents of Canada living with metastatic NSCLCRelease Date:Partner: Lung Health Foundation, Lung Cancer Canada, Quebec Lung AssociationQuality Improvement Oncology Canada Improving the Equity and Quality of Cancer Care in ColombiaRelease Date:Partner: The Colombian Association of Oncology and Hematology (ACHO)Quality Improvement Oncology Colombia Enhancing Molecular Testing for Metastatic Colorectal Cancer PatientsRelease Date:Partner: Colorectal Cancer Canada (CCC)Quality Improvement Oncology Canada Diagnosis and Diagnostic Tests for Metallo-β-Lactamase (MBL) Producing Bacterial InfectionsRelease Date:Education Hospital All IBD QORUS HEALTH EQUITY REQUEST FOR APPLICATIONS (RFA)Release Date:Partner: Crohn's & Colitis FoundationQuality Improvement Inflammation & Immunology USA